CENTENE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit Before the September 8th Deadline

Core Viewpoint - A class action lawsuit has been filed against Centene Corporation for allegedly misleading investors about its revenue outlook and growth projections during the specified class period from December 12, 2024, to June 30, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased Centene securities during the class period [1]. - Investors have until September 8, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Allegations Against Centene - The complaint alleges that Centene created a false impression of having reliable information regarding its projected revenue and growth, while actual enrollment rates and morbidity were lower than expected [3]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than anticipated, leading to a reduction in guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75 [4]. Group 3: Stock Impact - Following the announcement of the revised guidance, Centene's stock price plummeted from $56.65 per share on July 1, 2025, to $44.78 per share on July 2, 2025, marking a decline of over 40% [4].